If there is one book on HBOT you'd read

In this era of easy self-publishing, and the Amazons and the Flipkarts of the world making even the most arcane of titles within reach, one is spoilt for choices when it comes to reading up on any new topic. Even on something as esoteric as HBOT there are tons of books available, you just need to do a search on Amazon (the US site amazon.com, not the Indian site amazon.in).

But if there is just one book you would like to read to update yourself on HBOT, look no further than The Oxygen Revolution by Paul G Harch, MD, and Virginia McCullough. 

In the US, pretty much nothing can happen in the healthcare world without the approval of the FDA (Food & Drug Administration). FDA has approved HBOT for 14 medical conditions. But Dr Harch has extended the frontiers of oxygen therapy much beyond what is officially "approved". In this sense, he has been a real pathbreaker.

As a part of our outreach and professional education programme, we are thinking of making this book available in India in an affordable 'economy' edition.

Welcome to Bonphul Medsys' HBOT Blog

India is a fairly early-adopter of technology. Okay, okay hold on...may be not of everything, but at least in some areas we would be among the first few in the developing world. Military technology or space technology, for instance. Or, say, information technology. I have a sneaking suspicion that we would not be too far behind in medical technology as well.

Therefore it is surprising that very few in India are even aware--what to talk of usage--about hyperbaric oxygen therapy (HBOT).

Bonphul Medsys is a 10-year old healthcare equipment sales & marketing company. For the last 10 years it was known as Respirotech Med Solutions and, as the name suggest, sold respiration products. This year, however, the company decided to widen the scope of it business and took on a larger identity: of being a medical system 'MedSys' provider. Therefore when it came to creating a new portfolio of products with which to do business, the choice was obvious: oxygen therapy. It was in part led by the company's 10 years of experience of selling respiration products. But it was also prompted by the wide application that oxygen therapy is enjoying across the world.

Bonphul Medys would distribute high-pressure 'hard' oxygen chambers made by the American company Tekna, but would also manufacture and sell its own low-pressure 'soft' chambers.

As a part of our outreach to the medical community, patients and the informed public, we have decided to start a blog on HBOT. This would feature an informal, chatty, easy-going style of writing that would seek to demystify what might seem like exotic technology, and bring the focus to the only thing that matter: intervention outcome.

Happy reading!